Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 11 Deoxycortisol
2. 11 Desoxycortisol
3. 11 Desoxycortisone
4. 11-deoxycortisol
5. 11-desoxycortisol
6. 11-desoxycortisone
7. Cortexolone
8. Reichstein Substance S
9. Reichstein's Substance S
10. Reichsteins Substance S
11. Substance S, Reichstein's
1. Cortexolone
2. 11-deoxycortisol
3. 152-58-9
4. Reichstein's Substance S
5. 11-desoxycortisol
6. 11-deoxyhydrocortisone
7. Substance S
8. 17,21-dihydroxyprogesterone
9. Cortisol, 11-deoxy-
10. Reichstein S
11. 17,21-dihydroxypregn-4-ene-3,20-dione
12. 11-desoxyhydrocortisone
13. 17alpha-hydroxycortexone
14. 11-deoxy-17-hydroxycorticosterone
15. 11-deoxycortisone
16. 11-dioxycortisol
17. Reichstein's Compound S
18. Pregn-4-ene-3,20-dione, 17,21-dihydroxy-
19. 17-hydroxy-11-deoxycorticosterone
20. Sk&f 3050
21. 11-deoxy Cortisol
22. 11-desoxy-17-hydroxycorticosterone
23. 4-pregnene-17alpha,21-diol-3,20-dione
24. Cortifen
25. 17-alpha-hydroxycortexone
26. Cortodoxonum [inn-latin]
27. 17,21-dihydroxy-4-pregnene-3,20-dione
28. 17.alpha.-hydroxycortexone
29. Cortodoxona [inn-spanish]
30. Skf 3050
31. 17,21-dihydroxy-pregn-4-ene-3,20-dione
32. Nsc-18317
33. Corticosterone, 11-deoxy-17-hydroxy-
34. Wdt5slp0hq
35. Skf-3050
36. Mls000069440
37. Mls001333071
38. Chebi:28324
39. Sk&f-3050
40. Cortodoxone (usan)
41. Ncgc00021222-03
42. Smr000059123
43. 11-desoxy-17.alpha.-hydroxycorticosterone
44. 17alpha,21-dihydroxy-4-pregnene-3,20-dione
45. 4-pregnene-17.alpha.,21-diol-3,20-dione
46. Cortodoxone [usan]
47. Dsstox_cid_25642
48. Dsstox_rid_81022
49. 17.alpha.,21-dihydroxypregn-4-ene-3,20-dione
50. Dsstox_gsid_45642
51. (8r,9s,10r,13s,14s,17r)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-3-one
52. 11-desoxycortisone
53. Cortodoxona
54. Cortodoxonum
55. 17,21-dihydroxypregn-4-ene-3,20-dione (reichstein's Substance S)
56. 11 Deoxycortisol
57. Cas-152-58-9
58. Unii-wdt5slp0hq
59. Mfcd00003662
60. 17alpha,21-dihydroxypregna-4-ene-3,20-dione
61. Substance S, Reichstein's
62. 17-hydroxydesoxycorticosterone
63. Cortodoxone [usan:inn:ban]
64. Einecs 205-805-2
65. Brn 2511358
66. Opera_id_1433
67. Cortodoxone [inn]
68. 11-deoxycortisol Solution
69. Lopac0_001040
70. Schembl42590
71. 17a,21-dihydroxyprogesterone
72. 4-08-00-02913 (beilstein Handbook Reference)
73. Mls001333072
74. Chembl253144
75. Gtpl5100
76. Dtxsid8045642
77. Hms2234l16
78. Hms3263o21
79. (8r,9s,10r,13s,14s,17r)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3(2h)-one
80. Reichstein's Substance S, >=98%
81. Zinc3860956
82. Tox21_110867
83. Tox21_501040
84. Bdbm50423539
85. Cmc_13429
86. Lmst02030086
87. S4775
88. Akos015969740
89. Tox21_110867_1
90. Ccg-205117
91. Cs-5182
92. Lp01040
93. Sdccgsbi-0051010.p002
94. Ncgc00021222-04
95. Ncgc00021222-05
96. Ncgc00021222-06
97. Ncgc00021222-07
98. Ncgc00261725-01
99. As-56275
100. Hy-77839
101. 20-dione 17,21-dihydroxypregn-4-ene-3
102. 17.alpha.,21-dihydroxyprogesterone
103. Eu-0101040
104. C05488
105. C72891
106. D03595
107. Hydrocortisone Impurity F [ep Impurity]
108. R 0500
109. 11-desoxy-17-hydroxycorticosterone [mi]
110. 17alpha,21-dihydroxy-pregna-4-ene-3,20-dione
111. 152c589
112. A936328
113. Sr-01000076100
114. 4-pregnen-17.alpha.,21-diol-3,20-dione
115. Q2064915
116. Sr-01000076100-1
117. 17.alpha.,21-dihydroxy-4-pregnen-3,20-dione
118. .delta.4-pregnene-17.alpha.,21-diol-3,20-dione
119. 33bb233b-cc8f-413b-8901-3a73030bba68
120. 11-deoxycortisol (17,21-dihydroxypregn-4-ene-3,20-dione)
121. 17-(1-keto-2-hydroxyethyl)-4-androsten-17alpha, 21-ol-3-one
122. 17
123. A Inverted Exclamation Mark,21-dihydroxypregna-4-ene-3,20-dione
124. 11-deoxycortisol (17,21-dihydroxypregn-4-ene-3,20-dione) 1.0 Mg/ml In Methanol
125. (1s,2r,10r,11s,14r,15s)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one
126. (8r,10r,13s,17r)-17-hydroxy-17-(2-hydroxy-acetyl)-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
127. (8r,9s,10r,13s,14s,17r)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3h-cyclopenta[a]phenanthren-3-one
128. 11-deoxycortisol Solution, 1.0 Mg/ml In Methanol, Ampule Of 1 Ml, Certified Reference Material
129. 37-60-5
| Molecular Weight | 346.5 g/mol |
|---|---|
| Molecular Formula | C21H30O4 |
| XLogP3 | 2.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | 346.21440943 g/mol |
| Monoisotopic Mass | 346.21440943 g/mol |
| Topological Polar Surface Area | 74.6 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 652 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
17Beta-21-dihydroxyprogesterone is a known human metabolite of 17alpha-hydroxy-progesterone.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
Digital Content 
DATA COMPILATION #PharmaFlow
ANALYTICAL
ABOUT THIS PAGE
A Cortodoxone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cortodoxone, including repackagers and relabelers. The FDA regulates Cortodoxone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cortodoxone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cortodoxone supplier is an individual or a company that provides Cortodoxone active pharmaceutical ingredient (API) or Cortodoxone finished formulations upon request. The Cortodoxone suppliers may include Cortodoxone API manufacturers, exporters, distributors and traders.
Cortodoxone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cortodoxone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cortodoxone GMP manufacturer or Cortodoxone GMP API supplier for your needs.
A Cortodoxone CoA (Certificate of Analysis) is a formal document that attests to Cortodoxone's compliance with Cortodoxone specifications and serves as a tool for batch-level quality control.
Cortodoxone CoA mostly includes findings from lab analyses of a specific batch. For each Cortodoxone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cortodoxone may be tested according to a variety of international standards, such as European Pharmacopoeia (Cortodoxone EP), Cortodoxone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cortodoxone USP).
LOOKING FOR A SUPPLIER?
